英國Almac Group
Almac Clinical Technologies公司是Almac Group的子公司,專門致力于互動技術及服務解決方案,以提高臨床試驗流程的質量和效率。我們的解決方案包括針對隨機患者、跟蹤和臨床應用管理的互動電話及網絡回應系統(IXRS(TM))、用于電子化病例報告表數據收集的iTrial EDC、電子化患者報告結果數據收集以及網絡化藥品清單。Almac公司的技術在1300多項臨床試驗中得到了應用,涉及80多個國家,講50多種語言的150萬患者。
關于Almac Group
Almac Group由五家緊密結合的子公司組成,提供從研發、基因翻譯服務、API生產、配方研發、臨床試驗應用和技術(IVRS/EDC),到大規模生產的廣泛服務。Almac公司向包括制藥和生物技術領域的全球所有領先企業在內的600多家公司提供服務。公司擁有員工2000多名,總部位于北愛爾蘭的Craigavon,并在賓夕法尼亞州、北卡羅萊納州和加利福尼亞州開展美國業務。公司2008年7月投資1億美元開始興建新的北美總部,預計工程將于2010年竣工
Almac Group provides world-class, integrated solutions to the global pharmaceutical and biotechnology industries. Our services include process R&D, custom synthesis of API; micronization, 14C radio-labeling, formulation and analytical development; commercial-scale manufacture; packaging; storage; QP release; supply chain management; diagnostic/genomic services, preparation of clinical supplies and technology solutions (IVRS /Web/EDC).
Almac has the most comprehensive range of integrated drug development services available to the pharmaceutical / biotech industry. The privately owned company employing 2,200 dedicated professionals, is headquartered in Craigavon, Northern Ireland and has extensive facilities in the UK and US. Over 600 companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business. Click here to view our corporate video.
Almac's world-class pharmaceutical solutions extend from research, through development, to the commercialisation of product: